Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of Differences Between Alcohol-Related and Non-Alcohol-Related Cirrhosis Candidates

Jan-Paul Gundlach; Felix Braun; Finn Mötter; Alexander Bernsmeier; Pablo Barrio; Nicola Ehmke; Rainer Günther; Holger Hinrichsen; Thomas Becker; Wolfgang Weinmann; Alexandra Schröck; Michel Yegles; Friedrich Martin Wurst

doi:10.12659/AOT.936293

07 June 2022 : Original article

Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of Differences Between Alcohol-Related and Non-Alcohol-Related Cirrhosis Candidates

Jan-Paul Gundlach^1EF*, Felix Braun^1AD, Finn Mötter^1B, Alexander Bernsmeier^1CDE, Pablo Barrio^2E, Nicola Ehmke^1B, Rainer Günther^3B, Holger Hinrichsen^4A, Thomas Becker^1AD, Wolfgang Weinmann

^5B, Alexandra Schröck^6C, Michel Yegles^7C, Friedrich Martin Wurst^8ACDE

DOI: 10.12659/AOT.936293

Ann Transplant 2022; 27:e936293

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Overview of positive biomarker test results in patients with alcohol-related cirrhosis (n=25) or other liver diseases (n=41) in percent. uEtG and hEtG were tested in 65 patients, respectively. For PEth (n=66), patients with liver diseases other than alcohol-related cirrhosis showed a positive test result in over 50% of the cases, which is comparable to patients with alcohol-related cirrhosis. Figure prepared with PowerPoint 2019, Microsoft Corporation, Redmond/Washington, USA.

Back to the Article

Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of Differences Between Alcohol-Related and Non-Alcohol-Related Cirrhosis Candidates

Your Privacy